Jerusalem Venture Partners (JVP), founded and led by Dr. Erel Margalit, is an internationally renowned venture capital fund that stands at the forefront of global technology innovation. Since its founding in 1993, it has raised US$1.4 billion and has invested in more than 140 companies. During this period, JVP has led dozens of exits and launched a number of listings on Nasdaq, and as the leading Israeli venture capital fund, has been ranked by the research company, Preqin, as one of the top six most consistently performing venture capital funds in the world. JVP invests in early-stage start-ups and later-stage companies, artificial intelligence, big data, cyber-security, Digital Health, Enterprise Software, Insuretech, Fintech etc.
The fund operates the leading centers of excellence in Israel: the Media Quarter in Jerusalem; the CyberCenter in Beersheba; Foodtech in the Galillee, Digital Health in Haifa, and the International cyber center in New York. JVP’s innovation centers are seen as role models and magnets for strategic cooperation, drawing together a wide variety of sectors and technology giants across the globe. https://www.jvpvc.com/
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal and Metabolism, and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. In 2019, AstraZeneca has launched BeyondBio, its investment program in research and innovation in Israel. BeyondBio is part of a global network of innovation hubs and runs several projects in Israel with multiple partners. AstraZeneca opened its Israeli office in 2008.
Dr. Erel Margalit, Founder and Chairman of Jerusalem Venture Partners (JVP), one of the top six venture capital firms(VCs) worldwide. Recognized as one of the architects of the Start-up Nation, Dr. Margalit is a world-renowned business and social entrepreneur who developed a private public partnership (PPP) model to create tech-driven ecosystems in Jerusalem and Beer Sheva. Israel Initiative 2020 is a leading Israeli NGO (ii2020) was established by Dr. Erel Margalit in 2013, based on his socio-economic vision to advance higher quality employment within these regions. Recognizing the huge opportunity for growth, ii2020 is working to bring the innovation revolution to these regions, reducing the gaps and promoting prosperity throughout society creating seven regions of excellence from north to south.
The Kahn-Sagol-Maccabi Research and Innovation Institute (KSM) has developed international renown as one of the world’s finest medical research institutes. Our vision is to accelerate Precision and increase the amount and quality of medical research being performed at any given moment, in Israel and worldwide. KSM partners with the most advanced Researchers and AI companies to develop innovative, predictive and personalized tools in service of the new era of medicine. Our world renowned medical data-base consists of medical information of 2.5 million members, representing 25% of the Israeli market with a nationwide representative distribution collected for over 25 years, the database includes comprehensive, longitudinal diversified data such as demographic data, lab results, clinical visit records, pharmacy purchase data, scans and images.
Microsoft for Startups is a comprehensive global program designed to support startups as they build and scale their companies. Whether you’re looking to build your first application, land your first customer or scale to a million users, we’re here to help. From technical resources and free cloud to selling alongside Microsoft salespeople and the partner channel, we're invested in your success.
Shaare Zedek Scientific Ltd. (Mada’it) is a subsidiary of Shaare Zedek Medical Center, Jerusalem’s fastest growing major medical center which treats over 800,000 medical cases annually. Unique in our status as a private/public medical provider, Shaare Zedek provides a specific advantage in offering all the benefits and access of a major public healthcare institution. Our strength is in converting initial research initiatives into novel medical treatments by leveraging our hospital’s abilities, facilities, patients and expertise for the advancement of medical science. In multiple clinical realms, we offer our research partners unique access to clinical data, patients, materials and knowledge leading to specific scientific advantages.
Shaare Zedek Medical Center employs nearly 1000 physicians in 30 departments and 70 ambulatory units with over 1,000 patient beds. Our Emergency Medicine Department is the largest in Jerusalem and treats 150,000 patients every year. The maternity departments see over 22,000 deliveries annually, establishing Shaare Zedek as one of the world’s most active maternity hospitals.
Shaare Zedek Scientific, as a one-stop-shop, is the point of contact for companies in regards to all aspects of the interacting with the hospital, dedicated to promote an always-expanding and increasingly productive collaboration with key industry players.